Completed PHASE1 INTERVENTIONAL 2-arm NCT00685685

Fasting Bioavailability Study of Lovastatin Tablets and Mevacor Tablets

A Single Dose Crossover Comparative Bioavailability Study of Lovastatin 40mg Tablets in Healthy Male Volunteers/Fasting State

Sponsor: Mutual Pharmaceutical Company, Inc.

Conditions Healthy

Interventions Lovastatin (Mevacor®) 40 mg Tablets Lovastatin 40 mg tablets

Updated 6 times since 2017 Last updated: Jan 11, 2010 Started: Sep 30, 2004 Primary completion: Oct 31, 2004 Completion: Oct 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00685685, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by Mutual Pharmaceutical Company, Inc., it has been updated 6 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mutual Pharmaceutical Company, Inc.

Data source: Mutual Pharmaceutical Company, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada